It blocks NF- kβ activation which mediates immune responses (58); thus, TNFAIP3 plays a key role in controlling inflammation in autoimmune diseases and is suggested as an attractive candidate for drug targeting (59). This evidence concerns the gene TNFAIP3 and autoimmune disease.